Details of the Drug Formulaction

General Information of Drug Formulation (ID: F18883)

• Formulation Name: Ranolazine 500 mg tablet
• Company: Aphena Pharma Solutions-Tennessee; Cardinal Health; Carilion Materials Management; Gilead Sciences

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Ranolazine	(DM0C9IL)	Chronic/stable angina	BA40.1	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Eisenoxyd	(E00585)	56841934	Colorant
Ferric hydroxide oxide yellow	(E00539)	23320441	Colorant
Magnesium stearate	(E00208)	11177	lubricant
Polyethylene glycol 3350	(E00652)	Not Available	Coating agent; Diluent; Ointment base; Plasticizing agent; Solvent; Suppository base; lubricant
Polyvinyl alcohol	(E00666)	Not Available	Coating agent; Emulsion stabilizing agent; Film/Membrane-forming agent
Sodium hydroxide	(E00234)	14798	Alkalizing agent
Talc	(E00520)	16211421	Anticaking agent; Diluent; Glidant; lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent
Water	(E00035)	962	Solvent